what is the max dosage of tirzepatide Zepbound® Guide Tirzepatide Weekly Dosage Chart: Starting,

Tirzepatide, a dual GIP/GLP-1 receptor agonist, showed even more robust results in the SURPASS trials, with participants losing up to 22.5% of body weight

PMID: 38616273

New FDA-approved medication for weight loss (same active ingredient as Mounjaro)

Available data are insufficient to inform recommendations to mitigate the risk of pulmonary aspiration during general anesthesia or deep sedation in patients taking ZEPBOUND, including whether modifying preoperative fasting recommendations or temporarily discontinuing ZEPBOUND could reduce the incidence of retained gastric contents

When they do occur, symptoms are usually mild and improve as the body recovers

The risk of hypoglycemia increases when you use the medication with other diabetes medications such as sulfonylureas and insulin